NSPR InspireMD, Inc.
Price Chart
Executive Summary
Three directors at InspireMD (NSPR) purchased a total of $267K in open-market shares over the past week, representing 0.45% of market cap. This follows a strong Q1 earnings report with 122% revenue growth, but also a voluntary product recall and widening net losses, suggesting a mixed outlook but insider confidence.
Key Financial Metrics
Actionable Insight
The unanimous director buying after strong revenue growth suggests confidence in the long-term story despite short-term recall headwinds. Watch for follow-on C-suite purchases or further disclosures on FDA milestones (CGuard approval, CGUARDIANS III trial). The cluster size is modest relative to market cap, so it's a supportive signal but not a standalone catalyst.
Key Facts
- Three directors (Roubin, Ward, Stuka) purchased shares totaling $267K at prices $1.12-$1.19
- Purchases represent 0.45% of $59M market cap — modest but notable
- Q1 2026 revenue grew 122% YoY to $3.4M; net loss widened to $13.7M
- Voluntary recall of CGuard Prime 135 cm with estimated $1.35M in costs
- No C-suite insider buying in this cluster
Financial Impact
$267,000 in open-market purchases by directors
Risk Factors
- Voluntary recall may pressure near-term sales and margins
- Net losses continue to widen despite revenue growth
- Low market cap and liquidity could amplify volatility
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NSPR-1778628994544 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 21, 2026
24d ago
|
Insider Cluster
| $1.00 $0.9900 | ▼ −1.00% | ▼ −2.66% | $0.7300 (−27.00%) |
|
May 15, 2026
4w ago
|
Insider Cluster
| $1.05 $0.9500 | ▼ −9.52% | ▼ −11.14% | $0.7300 (−30.48%) |
|
May 7, 2026
5w ago
|
Insider Cluster
| $1.16 $1.17 | ▲ +0.86% | ▼ −0.64% | $0.7300 (−37.07%) |
|
May 1, 2026
6w ago
|
8-K
| $1.17 $1.25 | ▼ −6.84% | ▼ −3.90% | $0.7300 (+37.61%) |
|
May 1, 2026
6w ago
|
Press Release
| $1.17 $1.25 | ▼ −6.84% | ▼ −3.90% | $0.7300 (+37.61%) |
|
May 1, 2026
6w ago
|
Press Release
| $1.17 $1.25 | ▲ +6.84% | ▲ +3.90% | $0.7300 (−37.61%) |
|
Apr 22, 2026
7w ago
|
DEFA14A
| $1.28 $1.14 | ▼ −10.94% | ▼ −12.42% | $0.7300 (−42.97%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.33 $1.14 | ▼ −14.29% | ▼ −15.37% | $0.7300 (−45.11%) |
|
Apr 3, 2026
10w ago
|
424B5
| $1.49 $1.35 | ▲ +9.40% | ▲ +13.53% | $0.7300 (+51.01%) |
|
Mar 18, 2026
12w ago
|
8-K
| $1.79 $1.77 | ▼ −1.12% | ▼ −0.40% | $0.7300 (−59.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access